Antigenics Inc. (AGEN): Chairman and CEO Garo H. Armen Bought 1,708,717 Shares
Antigenics, Inc. (AGEN) reported a third quarter loss of $11.5 million or $0.25 per share compared to the previous year of $11.2 million or $0.24 per share. For the first nine-month in 2007, AGEN boosted their revenues to $4.7 million compared to $372,000 in 2006. The company recently agreed to receive $26.1 million in private placements. The biotechnology company develops treatments for cancers and infectious diseases. It offers Oncophage, a personalized therapeutic cancer vaccine candidate, which is in Phase III clinical trials for the treatment of renal cell car.
Antigenics Inc. has a market cap of $118.45 million; its shares were traded at around $2.41 with P/S ratio of 23.02.
Ruby Tuesday Inc. (RT): CEO Samuel E. Beall III Bought 350,000 Shares
The casual dining franchise, Ruby Tuesday, Inc. (RT), took in a loss of $10.4 million, or $0.20 a share for the second quarter ended in December, compared to a profit of $16.7 million, or $0.28 a year ago. The restaurant chain reported that their same-store sales in restaurant owned stores, and franchise owned stores dropped by 10.8%, and 8.7%, respectively. Ruby Tuesday’s shares recently are at its ten year low of around $5.70 a share.
CEO Samuel E. Beall III bought 350,000 shares of RT stock on last Friday at $5.99.
Other large insider buys were made between $5.94 and $15.75 since October of 2007:
Director Bernard Lanigan Jr. bought a total of 207,799 shares; Director James A. Haslam III bought 144,399 shares; Director Stephen Sadove I bought 75,000 shares; Sr. Vice President-Operations Kimberly Grant bought 6,000 shares; and finally, VP-Investor Relations&Planning Shannon Hepp bought a total of 1,800 shares.
Ruby Tuesday Inc. has a market cap of $350.61 million; its shares were traded at around $6.28 with P/E ratio of 6.79 and P/S ratio of 0.23. The dividend yield of Ruby Tuesday Inc. stocks is 5.9%.
NL Industries Inc. (NL): Chairman of the Board and CEO, Director, 10% Owner Harold C. Simmons Bought 55,100 Shares
NL Industries, Inc. (NL), suffered a third quarter net loss of $16 million or $0.33 in 2007, compared to a third quarter income of $3.3 million or $0.07 in 2006. The company faced a decrease in sales as competition rise from lower-priced Asian manufacturers. NL manufactures furniture and security components through its subsidiary, CompX International, Inc. NL also has 36% interest in the titanium oxide manufacturer Kronos Worldwide, Inc.
Chairman of the Board and CEO, Director, and the current 10% Owner of NL Industries Inc. Harold C. Simmons bought 55,100 shares on 01/11/08 at $9.92. Since November, Simmons has purchased a total of 117, 000 shares of NL stock at $9.14 to $9.94.
Industries Inc. has a market cap of $483.98 million; its shares were traded at around $9.92 with P/E ratio of 284.57 and P/S ratio of 2.69. The dividend yield of NL Industries Inc. stocks is 5.2%.
Zale Corp. (ZLC): President & CEO, Director Neal Goldberg Bought 11,000 Shares
The jewelry retailer, Zale Corporation (ZLC) made plans to close 60 of its stores: Zales, Gordon’s, and Piercing Pagoda. The company had lower than expected sales during the holiday season, where same-store sales dropped by 9% in November and December. ZLC widened their loss to $28.4 million or $0.58 in its first quarter ended in 10/31/07, compared to a loss of $26.4 million or $0.55 in 2006. The company said much of their loss has been owed to lower traffic in malls. Last September, Zales sold its Bailey Banks & Biddle chain for about $200 million to Finlay Enterprises Inc.
Robert Rodriguez increased his holdings by 24% to 2,205,000 shares as of 12/31/07.
President & CEO, Director of Zale Corp. Neal Goldberg bought 11,000 shares on 01/14/08 at $12.81. Other insider buys were made this week by EVP, CAO and CFO Rodney Carter, who bought 5,000 shares at $13.74; EVP, Chief Sourcing Officer Gilbert P. Hollander, who bought 3,735 at $13.38; and Director Thomas C. Shull, who bought 5,000 shares at $13.55. The current 10% Owner, Capital Management Llc Breeden, bought a total of 5,705,000 shares between $15.66 and $16.21 since 12/28/07. One sell was made by the President of Bailey Banks and Biddle, Charles E. Fieramosca, who sold 14,904 shares 10/19/07 at $22.41.
Zale Corp. has a market cap of $636.07 million; its shares were traded at around $12.81 with P/E ratio of 12.25 and P/S ratio of 0.23.